Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...
| Autore principale: | |
|---|---|
| Altri autori: | |
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
Elsevier
2007
|
| Soggetti: |